Literature DB >> 21918501

Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis.

Sean J Barbour1, Allen Greenwald, Ognjenka Djurdjev, Adeera Levin, Michelle A Hladunewich, Patrick H Nachman, Susan L Hogan, Daniel C Cattran, Heather N Reich.   

Abstract

The risk of venous thromboembolic events is thought to be highest in patients with membranous nephropathy. This association has been recently questioned, and it is not known whether this simply reflects the severity of proteinuria. To better understand the relationship between histologic diagnosis and the risk of venous thromboembolic events we evaluated patients in the Toronto Glomerulonephritis Registry. Of 1313 patients with idiopathic glomerulonephritis, 395 were diagnosed with membranous nephropathy, 370 with focal segmental glomerulosclerosis (FSGS), and 548 with immunoglobulin-A nephropathy (IgAN). Risk factors were evaluated by Cox proportional hazards for 53 image-confirmed venous thromboembolic events in 44 patients during a median follow-up of 63 months. The risk was highest in patients with membranous nephropathy and FSGS (hazard ratios of 22 and 7.8, respectively) referenced to patients with IgAN. Following adjustment for gender, cancer history, proteinuria, and serum albumin by multivariable analysis, the histologic subtype remained an independent risk for venous thromboembolic events. This risk was still highest in patients with membranous nephropathy followed by FSGS with adjusted hazard ratios of 10.8 and 5.9, respectively. Thus, in this large cohort, histologic diagnosis was an independent risk factor for venous thromboembolic events. Further studies are needed to discover mechanisms responsible for this high risk in patients with membranous nephropathy.

Entities:  

Mesh:

Year:  2011        PMID: 21918501     DOI: 10.1038/ki.2011.312

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  52 in total

1.  Venous thromboembolism in patients with membranous nephropathy.

Authors:  Sophia Lionaki; Vimal K Derebail; Susan L Hogan; Sean Barbour; Taewoo Lee; Michelle Hladunewich; Allen Greenwald; Yichun Hu; Caroline E Jennette; J Charles Jennette; Ronald J Falk; Daniel C Cattran; Patrick H Nachman; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Incidence and risk factors of venous thromboembolism in ANCA-associated vasculitis: a metaanalysis and metaregression.

Authors:  Panupong Hansrivijit; Angkawipa Trongtorsak; Kinjal P Gadhiya; Kriti Lnu; Christina T Dimech; Charat Thongprayoon; Wisit Cheungpasitporn; Stewart H Lecker
Journal:  Clin Rheumatol       Date:  2021-01-15       Impact factor: 2.980

3.  American Society of Nephrology quiz and questionnaire 2014: glomerular diseases.

Authors:  Andrew S Bomback; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-09       Impact factor: 8.237

4.  Hypercoagulable state evaluated by thromboelastography in patients with idiopathic membranous nephropathy.

Authors:  Meng-jie Huang; Ri-bao Wei; Qing-ping Li; Xi Yang; Cui-ming Cao; Ting-yu Su; Na Wang; Rui Wang; Xiang-mei Chen
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

Review 5.  Case Report: Acute Cerebellar Thrombosis in an Adult Patient with IgM Nephropathy.

Authors:  Abimbola Adike; Mariyam Cherry; Melina Awar
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Oct-Dec

6.  Patients with primary membranous nephropathy are at high risk of cardiovascular events.

Authors:  Taewoo Lee; Vimal K Derebail; Abhijit V Kshirsagar; Yunro Chung; Jason P Fine; Shannon Mahoney; Caroline J Poulton; Sophia Lionaki; Susan L Hogan; Ronald J Falk; Daniel C Cattran; Michelle Hladunewich; Heather N Reich; Patrick H Nachman
Journal:  Kidney Int       Date:  2016-02-26       Impact factor: 10.612

Review 7.  Role of direct oral anticoagulants in patients with kidney disease.

Authors:  Vimal K Derebail; Michelle N Rheault; Bryce A Kerlin
Journal:  Kidney Int       Date:  2019-12-24       Impact factor: 10.612

8.  Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.

Authors:  Taewoo Lee; Andrea K Biddle; Sofia Lionaki; Vimal K Derebail; Sean J Barbour; Sameer Tannous; Michelle A Hladunewich; Yichun Hu; Caroline J Poulton; Shannon L Mahoney; J Charles Jennette; Susan L Hogan; Ronald J Falk; Daniel C Cattran; Heather N Reich; Patrick H Nachman
Journal:  Kidney Int       Date:  2013-12-11       Impact factor: 10.612

9.  Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome.

Authors:  Nicholas Medjeral-Thomas; Stela Ziaj; Marie Condon; Jack Galliford; Jeremy Levy; Tom Cairns; Megan Griffith
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 8.237

10.  Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome.

Authors:  Bryce A Kerlin; Amanda P Waller; Ruchika Sharma; Melinda A Chanley; Marvin T Nieman; William E Smoyer
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.